查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1546187

全球血管成像市場

Vascular Imaging
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球血管成像市場將達到 119 億美元

全球血管成像市場預計 2023 年為 86 億美元，預計到 2030 年將達到 119 億美元，2023-2030 年分析期間複合年成長率為 4.7%。 MRI 是本報告分析的細分市場之一，預計複合年成長率為 4.8%，到分析期結束時將達到 55 億美元。分析期內，CT 細分市場的複合年成長率預計為 4.9%。

美國市場預期成長23億美元，中國複合年成長率為8.3%

預計 2023 年美國血管成像市場規模將達 23 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達27億美元，2023-2030年分析期間複合年成長率為8.3%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 1.6% 和 4.9%。在歐洲，德國的複合年成長率預計為 2.1%。

全球血管成像市場 - 主要趨勢和促進因素總結

是什麼推動了血管成像技術的採用？

血管成像技術提供血管和循環系統的詳細可視化，對於血管疾病的診斷和治療至關重要。心血管和周邊血管疾病的盛行率不斷增加，對超音波、磁振造影血管造影術（MRA）和電腦斷層掃描（CTA）等先進影像方式的需求急劇增加。這些技術提供了對血管狀態的重要見解，從而可以進行早期診斷、準確的治療計劃和有效監測疾病進展。隨著醫療保健提供者努力改善患者的治療效果並減輕血管疾病的負擔，血管成像技術的採用預計將持續成長並推動市場擴張。

科技進步如何增強血管成像？

技術的進步極大地提高了血管成像的能力，使其更加準確、非侵入性且易於使用。高解析度成像系統和顯影劑的發展提高了血管影像的清晰度和細節，可以更好地檢測異常和閉塞。將人工智慧 (AI) 和機器學習演算法整合到成像系統中，透過實現自動影像分析和預測診斷，進一步徹底改變了該領域。此外，攜帶式和照護現場成像設備的技術創新使血管成像變得更加容易，特別是在偏遠和服務不足的地區。這些技術進步正在推動血管成像技術的廣泛使用，因為它們為血管疾病的診斷和管理提供了更高的準確性和便利性。

血管影像有哪些新趨勢？

血管成像市場正在見證一些正在塑造其成長和開拓的新興趨勢。一個顯著的趨勢是擴大使用混合成像技術，例如 PET/CT 和 PET/MRI。另一個趨勢是，由於需要減少患者的不適和與侵入性操作相關的併發症的風險，因此越來越重視非侵入性影像方式。對個人化醫療不斷成長的需求也對市場產生了影響，影像技術擴大被用來根據個別患者的情況量身定做治療計劃。此外，人工智慧主導的影像分析的廣泛使用可以更準確、更快速地解釋血管影像，從而提高診斷準確性和效率。

推動血管成像市場成長的因素有哪些？

血管影像市場的成長受到多種因素的推動，包括動脈粥狀硬化、動脈瘤和深層靜脈栓塞症等血管疾病盛行率的上升。另一個主要促進因素是，由於人們對預防性醫療保健重要性的認知不斷增強，對早期準確診斷的需求不斷成長。此外，診斷影像技術的不斷進步，包括開發更先進的非侵入性影像系統，正在擴大醫療保健提供者可用的診斷選擇範圍。向基於價值的醫學的轉變強調準確診斷在改善患者治療結果和降低醫療成本方面的重要性，這進一步推動了血管成像技術的採用。此外，在政府措施和財政支持的支持下，對血管成像領域研究和開發的日益關注也促進了市場的成長。

受訪企業範例（18家知名企業）

  • Abbott Laboratories
  • Carestream Health, Inc.
  • Esaote SpA
  • Fujifilm Corporation
  • GE Healthcare
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Samsung Medison Co., Ltd.
  • Shimadzu Medical Systems USA
  • Siemens AG
  • Terumo Corporation
  • Toshiba Corporation

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP15455

Global Vascular Imaging Market to Reach US$11.9 Billion by 2030

The global market for Vascular Imaging estimated at US$8.6 Billion in the year 2023, is expected to reach US$11.9 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. MRI, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$5.5 Billion by the end of the analysis period. Growth in the CT segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 8.3% CAGR

The Vascular Imaging market in the U.S. is estimated at US$2.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2030 trailing a CAGR of 8.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Vascular Imaging Market - Key Trends & Drivers Summarized

What Is Driving the Adoption of Vascular Imaging Technologies?

Vascular imaging technologies have become indispensable in the diagnosis and management of vascular diseases, offering detailed visualizations of blood vessels and circulatory systems. The increasing prevalence of cardiovascular and peripheral vascular diseases has led to a surge in the demand for advanced imaging modalities such as ultrasound, magnetic resonance angiography (MRA), and computed tomography angiography (CTA). These technologies provide critical insights into vascular conditions, enabling early diagnosis, precise treatment planning, and effective monitoring of disease progression. As healthcare providers strive to improve patient outcomes and reduce the burden of vascular diseases, the adoption of vascular imaging technologies is expected to grow, driving market expansion.

How Are Technological Advancements Enhancing Vascular Imaging?

Technological advancements have significantly enhanced the capabilities of vascular imaging, making it more accurate, non-invasive, and accessible. The development of high-resolution imaging systems and contrast agents has improved the clarity and detail of vascular images, allowing for better detection of abnormalities and blockages. The integration of artificial intelligence (AI) and machine learning algorithms into imaging systems has further revolutionized the field, enabling automated image analysis and predictive diagnostics. Additionally, innovations in portable and point-of-care imaging devices have made vascular imaging more accessible, particularly in remote or underserved regions. These technological advancements are driving the widespread adoption of vascular imaging technologies, as they offer greater precision and convenience in the diagnosis and management of vascular diseases.

What Are the Emerging Trends in Vascular Imaging?

The vascular imaging market is witnessing several emerging trends that are shaping its growth and development. One notable trend is the increasing use of hybrid imaging techniques, such as PET/CT and PET/MRI, which combine the strengths of different imaging modalities to provide more comprehensive and accurate assessments of vascular conditions. Another trend is the growing emphasis on non-invasive imaging methods, driven by the need to reduce patient discomfort and the risk of complications associated with invasive procedures. The rise in demand for personalized medicine is also influencing the market, as imaging technologies are increasingly being used to tailor treatment plans based on individual patient profiles. Furthermore, the expanding use of AI-driven imaging analytics is enabling more precise and faster interpretation of vascular images, improving diagnostic accuracy and efficiency.

What Factors Are Driving the Growth of the Vascular Imaging Market?

The growth in the vascular imaging market is driven by several factors, including the rising prevalence of vascular diseases such as atherosclerosis, aneurysms, and deep vein thrombosis. The increasing demand for early and accurate diagnosis, fueled by the growing awareness of the importance of preventive healthcare, is also a significant driver. Additionally, the continuous advancements in imaging technologies, including the development of more sophisticated and non-invasive imaging systems, are expanding the range of diagnostic options available to healthcare providers. The shift towards value-based care, which emphasizes the importance of accurate diagnostics in improving patient outcomes and reducing healthcare costs, is further boosting the adoption of vascular imaging technologies. Moreover, the growing focus on research and development in the field of vascular imaging, supported by government initiatives and funding, is contributing to the market's growth.

Select Competitors (Total 18 Featured) -

  • Abbott Laboratories
  • Carestream Health, Inc.
  • Esaote SpA
  • Fujifilm Corporation
  • GE Healthcare
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Samsung Medison Co., Ltd.
  • Shimadzu Medical Systems USA
  • Siemens AG
  • Terumo Corporation
  • Toshiba Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Vascular Imaging - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Non-invasive Imaging Techniques
    • Technological Advancements in Vascular Ultrasound
    • Growth of MRI and CT Angiography in Vascular Diagnostics
    • Adoption of AI and Machine Learning in Vascular Imaging Analysis
    • Increasing Use of Portable and Handheld Imaging Devices
    • Expanding Applications of Vascular Imaging in Disease Screening
    • Innovations in Contrast Media and Imaging Agents
    • Integration of Imaging with Vascular Interventional Procedures
    • Growing Awareness and Early Diagnosis of Vascular Conditions
    • Cost-effectiveness and Accessibility of New Imaging Modalities
    • Rising Prevalence of Cardiovascular Diseases Globally
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Vascular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for CT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for X-Ray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for X-Ray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for X-Ray by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Nuclear Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Nuclear Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Nuclear Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Vascular Imaging Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • JAPAN
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • CHINA
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • EUROPE
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Vascular Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • FRANCE
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • GERMANY
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Vascular Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • INDIA
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Vascular Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Vascular Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • AFRICA
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030

IV. COMPETITION